Core Insights - The "2025 China Sleep Medicine Development Forum" was held in Beijing, focusing on new data, methods, and initiatives for insomnia treatment to promote national sleep health and contribute to a healthier China [1][4]. Group 1: Sleep Issues in China - The sleep disturbance rate among individuals aged 18 and above in China is 48.5%, indicating a growing public concern regarding sleep quality [4]. - Symptoms of insomnia include difficulty falling asleep, waking up multiple times during the night, early morning awakening, and daytime sleepiness, which, if occurring more than three times a week for over three months, warrant medical consultation [4]. Group 2: Evolving Understanding of Quality Sleep - The understanding of "quality sleep" has evolved to encompass not just nighttime rest but also its impact on daytime mental state, work efficiency, and overall life experience [4]. - The treatment goal for insomnia has shifted from merely achieving sleep to ensuring both good sleep quality and daytime functionality [4]. Group 3: Advances in Sleep Research - The discovery of the orexin system in 1998 has significantly advanced sleep and neuroscience, with the notion that insomnia is fundamentally linked to excessive wakefulness [5]. - Dual orexin receptor antagonists are being explored to help restore natural sleep-wake rhythms, aiming for a balance of good sleep at night and alertness during the day [5]. Group 4: National Initiatives and Projects - The National Health Commission plans to ensure that at least one hospital in every city provides "sleep clinic services" by 2025, as part of its commitment to public health [5]. - A nationwide sleep disorder screening project was launched in 2023, with 266 medical institutions certified to monitor sleep patterns, aiming to reduce healthcare costs and alleviate patient burdens [5].